Biotech Laboratories (Pty) Ltd v Beecham Group Plc and Another (494/2000) [2002] ZASCA 11; 2002 (4) SA 249 (SCA); [2002] 3 All SA 652 (SCA) (25 March 2002)

Biotech Laboratories (Pty) Ltd v Beecham Group Plc and Another (494/2000) [2002] ZASCA 11; 2002 (4) SA 249 (SCA); [2002] 3 All SA 652 (SCA) (25 March 2002)

The Supreme Court of Appeal held that the package insert for Augmentin is an original literary work within the meaning of the Copyright Act, as it was compiled using skill and judgment by Smith-Kline Beecham's staff. The fact that the insert incorporated prior material and underwent amendments during the Medicines Control Council's approval process did not detract from its originality. The Court found that the MCC did not direct or control the creation of the insert, but merely approved its compliance with regulatory requirements. Therefore, copyright does not vest in the State under section 5(2) of the Act. The copyright in the insert vests in Smith-Kline Beecham, and Biotech...

Citation
[2002] ZASCA 11
Parties
Appellant: Biotech Laboratories (Pty) Ltd; Respondent: Beecham Group Plc; Respondent: Smith-Kline Beecham Pharmaceuticals (Pty) Ltd
Court
Supreme Court of Appeal
Jurisdiction
South Africa
Judgment Date
25 March 2002
Case Number
494/2000
Procedural Posture
Civil Appeal / Appeal From the High Court
Outcome
Appeal dismissed with costs, including costs of two counsel.
Judges
Nienaber, Harms, Zulman, Navsa, Nugent
Legal Topics
Copyright Originality, State Copyright, Package Insert, Compilation, Ownership of Copyright
Intellectual Property Copyright Originality State Copyright Package Insert Compilation Ownership of Copyright

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 9 Party arguments 2
Sign in to unlock

Parties

Biotech Laboratories (Pty) Ltd

Appellant

Beecham Group Plc

Respondent

Smith-Kline Beecham Pharmaceuticals (Pty) Ltd

Respondent

Procedural Posture

Civil Appeal / Appeal From the High Court

Legal Issues

  1. 1 Whether the package insert for Augmentin is an 'original' literary work eligible for copyright protection.
  2. 2 Whether copyright in the package insert vests in the State under section 5(2) of the Copyright Act 98 of 1978.
  3. 3 Whether Biotech Laboratories infringed Smith-Kline Beecham's copyright by copying the package insert.

Ratio Decidendi

The Supreme Court of Appeal held that the package insert for Augmentin is an original literary work within the meaning of the Copyright Act, as it was compiled using skill and judgment by Smith-Kline Beecham's staff. The fact that the insert incorporated prior material and underwent amendments during the Medicines Control Council's approval process did not detract from its originality. The Court found that the MCC did not direct or control the creation of the insert, but merely approved its compliance with regulatory requirements. Therefore, copyright does not vest in the State under section 5(2) of the Act. The copyright in the insert vests in Smith-Kline Beecham, and Biotech...

Court Disposition

Appeal dismissed with costs, including costs of two counsel.

Orders

  • The appeal is dismissed.
  • The appellant is ordered to pay the respondents' costs, including the costs of two counsel.